Structure of Almonertinib
CAS No.: 1899921-05-1
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
HS-10296 is the third-generation EGFR TKIs which exhibited inhibitory effect on both EGFR-activating mutations and T790M-resistant mutation.
Synonyms: HS-10296; Ameile; Aumolertinib
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1899921-05-1 |
Formula : | C30H35N7O2 |
M.W : | 525.64 |
SMILES Code : | C=CC(NC1=CC(NC2=NC=CC(C3=CN(C4CC4)C5=C3C=CC=C5)=N2)=C(OC)C=C1N(CCN(C)C)C)=O |
Synonyms : |
HS-10296; Ameile; Aumolertinib
|
MDL No. : | MFCD32173681 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
LU0387 cells | 312 nM | 7 days | Evaluate the inhibitory effect of Almonertinib on the proliferation of LU0387 cells with EGFR NPH mutation | PMC10326255 |
Human NSCLC cell lines HCC827 | 0.0003, 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1 μM | 72 h | To determine the IC50 of Almonertinib on HCC827 cells, results showed significant inhibitory effects in EGFR-del19 mutant cells. | PMC9063085 |
Human NSCLC cell lines H1975 | 0.01, 0.1, 1, 10, 20, 50, 100 μM | 72 h | To determine the IC50 of Almonertinib on H1975 cells, results showed significant inhibitory effects in EGFR L858R/T790M mutant cells. | PMC9063085 |
Human NSCLC cell lines A549 | 1, 2, 5, 10, 20, 50, 100 μM | 72 h | To determine the IC50 of Almonertinib on A549 cells, results showed weak inhibitory effects in EGFR wild-type cells. | PMC9063085 |
HCC827/AR cells | 8 μM | 24 h | To evaluate the effects of Almonertinib combined with Baicalein on cell proliferation and apoptosis. Results showed that the combination significantly inhibited cell proliferation and induced apoptosis. | PMC11322074 |
H1975/AR cells | 8 μM | 24 h | To evaluate the effects of Almonertinib combined with Baicalein on cell proliferation and apoptosis. Results showed that the combination significantly inhibited cell proliferation and induced apoptosis. | PMC11322074 |
BCRP-MDCK monolayer cells | 1, 10, 20 μM | 4 h | To study the transport characteristics of Almonertinib in BCRP-MDCK cells, results showed an efflux ratio of 4.62 at 1 μM concentration | PMC8497791 |
ABCB1-MDCK monolayer cells | 1, 10, 20 μM | 4 h | To study the transport characteristics of Almonertinib in ABCB1-MDCK cells, results showed an efflux ratio of 5.2 at 1 μM concentration | PMC8497791 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
BALB/c nude mice | Ba/F3 EGFR ASV and L861Q allografts model | Oral | 20 and 40 mg/kg | Once daily for 13 days | Evaluate the inhibitory effect of Almonertinib on tumor growth with EGFR ASV and L861Q mutations | PMC10326255 |
Balb/c nude mice | H1975 and HCC827 xenograft model | Oral | 20 mg/kg | Once daily, multiple cycles (4 days per cycle) | To evaluate the anti-tumor effect of Almonertinib in H1975 and HCC827 xenograft models, results showed that P-A sequence (pemetrexed followed by Almonertinib) exhibited significant synergistic anti-tumor effects. | PMC9063085 |
BALB/c nude mice | Subcutaneous HCC827/AR cell xenograft model | 15 mg/kg | 24 days | To evaluate the inhibitory effects of Almonertinib combined with Baicalein on tumor growth. Results showed that the combination significantly inhibited tumor growth. | PMC11322074 | |
BALB/c nude mice | PC9-LUC brain and spinal cord metastasis models | Oral | 5, 10, 25 mg/kg | Once daily for 60 days | To evaluate the anti-tumor efficacy of Almonertinib in brain and spinal cord metastasis models, results showed that 25 mg/kg Almonertinib significantly inhibited tumor growth and prolonged survival time | PMC8497791 |
Rats | Healthy SD rats | Oral | 15 mg/kg | For nine consecutive days | To evaluate the pharmacokinetic interactions between almonertinib and rivaroxaban or apixaban. Results showed that almonertinib significantly increased the plasma concentration and AUC of rivaroxaban and apixaban, and decreased their clearance. | PMC10582335 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT04785742 | Safety of Almonertinib | PHASE2 | UNKNOWN | 2023-12-31 | Sun Yat-sen University Cancer ... More >>Center, Guangzhou, Guang Dong, China Less << |
NCT04952168 | NSCLC, Stage III | PHASE2 | UNKNOWN | 2023-06-02 | Tongji Hospital of Tongji Medi... More >>cal College of Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China Less << |
NCT04922138 | Lung Cancer | PHASE2 | RECRUITING | 2025-10-15 | Shanghai Chest Hospital, Shang... More >>hai, Shanghai, 200000, China|Shanghai Pulmonary Hospital, Shanghai, Shanghai, 200000, China Less << |
NCT04636593 | Non Small Cell Lung Cancer|Sta... More >>ge III NSCLC|EGFR Activating Mutation Less << | PHASE2 | UNKNOWN | 2022-12-31 | Hangzhou Cancer hospital, Hang... More >>zhou, Zhejiang, 310002, China Less << |
NCT06463171 | Lung Cancer Non-small Cell Sta... More >>ge IV Less << | PHASE2 | NOT_YET_RECRUITING | 2025-06-26 | Zhongshan hospital, Shanghai, ... More >>200032, China|The First Affiliated Hospital of Xiamen University, Xiamen, 361003, China Less << |
NCT04354961 | Pulmonary Adenosquamous Carcin... More >>oma Less << | PHASE2 | RECRUITING | 2025-06-30 | Beijing Cancer Hospital, Beiji... More >>ng, China|Beijing Chest Hospital, Capital Medical University, Beijing, China|Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China|Hunan Cancer Hospital, Changsha, China|The Second Xiangya Hospital of Central South University, Changsha, China|Xinqiao Hospital, Army Medical University, Chongqing, China|Fujian Cancer Hospital, Fuzhou, China|Fujian Provincial Hospital, Fuzhou, China|Sir Run Run Shaw Hospital, Hangzhou, China|The second Affiliated Hospital of Kunming Medical University, Kunming, China|The second Affiliated Hospital of Nanchang University, Nanchang, China|Jiangsu Province Hospital, Nanjing, China|Shanghai Chest Hospital, Shanghai, China|Tianjin Medical University Cancer Institute & Hospital, Tianjin, China|Tongji Hospital of Tongji Medical College,Huazhong University of Science and Technology, Wuhan, China|Air Force Medical University of PLA (the Fourth Military Medical University), Xi'an, China|Henan Cancer Hospital, Zhengzhou, China|Henan Provincial People's Hospital, Zhengzhou, China Less << |
NCT06227897 | Lung Cancer | PHASE2 | WITHDRAWN | 2029-04-01 | Sun Yat-sen University Cancer ... More >>Center, Guangzhou, Guangdong, 510060, China Less << |
NCT04841811 | Lung Cancer | PHASE3 | RECRUITING | 2026-12-31 | Guangdong Lung cancer institut... More >>e, Guangzhou, Guangdong, 510080, China Less << |
NCT05662813 | Non-small Cell Lung Cancer | PHASE2 | RECRUITING | 2025-06-30 | West China Hospital,Sichuan Un... More >>iversity, Chendu, Sichuan, China Less << |
NCT05994339 | Lung Cancer Stage III | PHASE2|PHASE3 | NOT_YET_RECRUITING | 2025-12-08 | - |
NCT04882345 | Lung Cancer|EGFR Gene Mutation | PHASE2 | UNKNOWN | 2024-01-15 | - |
NCT05826483 | Malignant Tumor of Lung|Poor P... More >>erformance Status Less << | PHASE1 | RECRUITING | 2024-12-30 | Zhou Chengzhi, Guangzhou, Guan... More >>gdong, 510120, China Less << |
NCT05946460 | Lung Cancer | PHASE2 | RECRUITING | 2025-07-10 | The First Affiliated Hospital ... More >>of Guangzhou Medical University, Guangzhou, Guangdong, 510000, China Less << |
NCT02981108 | Nonsmall Cell Lung Cancer | PHASE1|PHASE2 | UNKNOWN | 2023-03-31 | Pacific Cancer Medical Center,... More >> Inc., Anaheim, California, 92801, United States|Beverly Hills Cancer Center, Beverly Hills, California, 90211, United States|University of California San Diego Medical Center Moores Cancer Center, San Diego, California, 92093, United States|University of Colorado-1775 Aurora Court, Aurora, Colorado, 80045, United States|Sylvester Comprehensive Cancer Center, Deerfield Beach, Florida, 33442, United States|University Cancer & Blood Center, LLC, Athens, Georgia, 30607, United States|Baptist Healthcare Systems Inc. Baptist Health Floyd, New Albany, Indiana, 47150, United States|Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire, 03755, United States|University of Texas Medical Branch at Galveston, Galveston, Texas, 77550, United States|MultiCare Institute for Research and Innovation, Tacoma, Washington, 98405, United States Less << |
NCT04643847 | EGFR Positive Non-small Cell L... More >>ung Cancer|Brain Metastases Less << | PHASE2 | UNKNOWN | 2023-11-30 | Hangzhou Cancer Hospital, Hang... More >>zhou, Zhejiang, 310002, China Less << |
NCT04553887 | Non Small Cell Lung Cancer | PHASE2 | UNKNOWN | 2023-05-01 | Tianjin Medical University Can... More >>cer Institute and Hospital, Tianjin, Tianjin, China Less << |
NCT04808752 | Lung Cancer | PHASE2 | ACTIVE_NOT_RECRUITING | 2024-07-15 | Cancer Hospital Affiliated to ... More >>University of Chinese Academy of Sciences, Hangzhou, Zhejiang, 310000, China Less << |
Tags: Almonertinib | HS-10296 | HS10296 | HS 10296 | EGFR | Epidermal growth factor receptor | ErbB-1 | HER1 | oral | antineoplastic | mutations | G719X | del19 | L858R | L861Q | non-small | cell | lung cancer | NSCLC | 1899921-05-1
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL